Agios Pharmaceuticals, Inc. share price logo

Agios Pharmaceuticals, Inc. Share Price

NASDAQ: AGIO

Mid Cap

$38.29

+1.57

(+4.28%)

Live

as on

Agios Pharmaceuticals, Inc. Stock Performance

as on September 17, 2025 at 8:42 pm IST

  • Day's Low

    Day's High

    $36.98
    $38.44
    downward going graph

    3.42%

    Downside

    0.39%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $23.42
    $62.58
    downward going graph

    38.85%

    Downside

    63.44%

    Upside

    downward going graph

Agios Pharmaceuticals, Inc. share price movements today

Previous Close
$36.72
Open
$37.20
Volume
191.2K
Day's Low - High
$36.98 - $38.44
52 Week Low - High
$23.42 - $62.58

Agios Pharmaceuticals, Inc. Historical Returns

1 Month Return
-1.92 %
3 Month Return
+ 4.64 %
1 Year Return
-20.55 %
3 Year Return
+ 17.7 %
5 Year Return
-6.13 %

Agios Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check Agios Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

-7.4043

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

3.25

Industry PE ratio

10.127857142857144

P/B Ratio

3.2524

PEG Ratio

0

EBITDA

-456.3M

Revenue (TTM)

40.9M

Profit Margin

1590.42%

Return On Equity TTM

64.05%

Agios Pharmaceuticals, Inc. Stock Valuation

Track how Agios Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.

Agios Pharmaceuticals, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (1.81x)

December 31, 2021

Today (3.25x)

September 17, 2025

Industry (10.13x)

September 17, 2025

Highest (2.47x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 3.25x

Agios Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Agios Pharmaceuticals, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.1B-6.13%3.251590.42%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Agios Pharmaceuticals, Inc. Stock including INR - Dollar returns

The Agios Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Agios Pharmaceuticals, Inc. investment value today

Current value as on today

₹88,402

Returns

₹11,598

(-11.6%)

Returns from Agios Pharmaceuticals, Inc. Stock

₹16,196 (-16.2%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Agios Pharmaceuticals, Inc. Stock

Based on 15 analysts

BUY

73.33%

Buy

26.67%

Hold

0.00%

Sell

Based on 15 analysts, 73.33% of analysts recommend a 'BUY' rating for Agios Pharmaceuticals, Inc.. Average target price of $47.5

Agios Pharmaceuticals, Inc. Share Price Target

Get share price movements and forecasts by analysts on Agios Pharmaceuticals, Inc..

What analysts predicted

19.39%UPSIDE

Target Price

$47.5

Current Price

$38.29

Analyzed by

15 Analysts

Target

$47.50

Agios Pharmaceuticals, Inc. target price $47.5, a slight upside of 19.39% compared to current price of $38.29. According to 15 analysts rating.

Agios Pharmaceuticals, Inc. Stock's Interest Amongst Investors

Search interest for Agios Pharmaceuticals, Inc. Stock has increased by 160% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:160% versus previous 30 day period

Agios Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
5
6
7
7
8
8
8
10
8
12
Gross Profit
5
5
6
5
6
5
8
9
7
9
Operating Income
-90
-93
-100
-106
-92
-105
-102
-125
-106
-127
EBITDA
-88
-91
-99
-104
-90
-104
-102
-123
-105
-110
Interest Expense
9
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-81
-83
-91
-95
-81
-96
1,001
-105
-89
-112
Income Tax Expense
-9
-10
-9
1
1
-
53
-8
-
-
Net Income
-71
-83
-91
-95
-81
-96
947
-96
-89
-112
Net Profit Margin
-1273.36%
-1248.60%
-1234.27%
-1350.70%
-995.84%
-1115.71%
10574.69%
-899.56%
-1023.25%
-899.40%

Agios Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
59
69
43
94
117
203
0
14
26
36
Gross Profit
59
69
43
92
116
200
-18
12
17
32
Operating Income
-118
-200
-320
-362
-426
-316
-378
-389
-391
-425
EBITDA
-115
-195
-314
-355
-394
-326
-337
-380
-384
-425
Interest Expense
0
2
6
16
14
17
0
12
-
-
Depreciation
-
-
6
7
8
9
9
8
6
5
Income Before Tax
-117
-198
-314
-346
-411
-327
-356
-231
-352
717
Income Tax Expense
0
-5
-6
32
-14
7
-1,977
-157
6
44
Net Income
-117
-198
-314
-346
-396
-335
1,604
-74
-352
673
Net Profit Margin
-199.14%
-283.97%
-731.60%
-366.61%
-336.36%
-164.97%
3875280.74%
-523.56%
-1312.63%
1845.92%

Agios Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-83
-91
-95
-81
-96
947
-96
-89
-112
Operating Cash Flow
-66
-61
-72
-99
-72
-84
-133
-111
-77
Investing Cash Flow
47
39
95
124
37
250
-49
112
78
Financing Cash Flow
0
1
0
5
1
2
4
1
0
Change in Cash
-19
-20
23
30
-34
169
-177
2
1

Agios Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-198
-314
-346
-411
-327
-356
-231
-352
673
Operating Cash Flow
38
-285
-304
-370
-290
-407
-309
-296
-389
Investing Cash Flow
-119
-57
-273
91
75
1,248
243
239
363
Financing Cash Flow
169
285
546
289
261
-765
2
5
14
Change in Cash
88
-58
-32
10
46
75
-63
-51
-11

Global Institutional Holdings in Agios Pharmaceuticals, Inc.

Funds
Holdings
Farallon Capital Management, L.L.C.
9.81%
Vanguard Group Inc
9.65%
BlackRock Inc
8.79%
Bellevue Group AG
6.05%
State Street Corp
4.22%

Insights on Agios Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 8.72M → 12.45M (in $), with an average increase of 29.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AGIO stock has moved up by 2.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 97.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 87.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -89.28M → -112.02M (in $), with an average decrease of 25.5% per quarter

About Agios Pharmaceuticals, Inc.

at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
OrganisationAgios Pharmaceuticals, Inc.
Headquarters88 Sidney Street, Cambridge, MA, United States, 02139
IndustryHealth Technology
CEOMr. Brian M. Goff M.B.A.
E-voting on sharesClick here to vote

Key Management of Agios Pharmaceuticals, Inc.

Name

Title

Mr. James William Burns

Corporate Secretary & Chief Legal Officer

Mr. Brian M. Goff M.B.A.

CEO & Director

Ms. Cecilia Jones

Chief Financial Officer

Dr. Lewis clayton Cantley Ph.D.

Co-Founder

Dr. Tak Wah Mak D.Sc., FRSC, Ph.D.

Co-Founder

Dr. Craig B. Thompson M.D.

Co-Founder

Dr. Shin-San Su Ph.D.

Co-Founder

Mr. T. J. Washburn

VP, Controller & Principal Accounting Officer

Dr. Sarah Gheuens M.D., Ph.D.

Chief Medical Officer and Head of Research & Development

Ms. Tsveta Milanova

Chief Commercial Officer

FAQs

What is Agios Pharmaceuticals, Inc. share price today?

Agios Pharmaceuticals, Inc. share price today is $38.29 as on . Agios Pharmaceuticals, Inc. share today touched a day high of $38.44 and a low of $36.98.

What is the 52 week high and 52 week low for Agios Pharmaceuticals, Inc. share?

Agios Pharmaceuticals, Inc. share touched a 52 week high of $62.58 on and a 52 week low of $23.42 on . Agios Pharmaceuticals, Inc. stock price today i.e. is trending at $38.29,which is 38.81% down from its 52 week high and 63.53% up from its 52 week low.

What is Agios Pharmaceuticals, Inc.'s market capitalisation today?

Agios Pharmaceuticals, Inc. market capitalisation is $0.00T as on .

How to invest in Agios Pharmaceuticals, Inc. Stock (AGIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Agios Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Agios Pharmaceuticals, Inc. Shares that will get you 0.0392 shares as per Agios Pharmaceuticals, Inc. share price of $38.29 per share as on September 17, 2025 at 8:42 pm IST.

What is the minimum amount required to buy Agios Pharmaceuticals, Inc. Stock (AGIO) from India?

Indian investors can start investing in Agios Pharmaceuticals, Inc. (AGIO) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Agios Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Agios Pharmaceuticals, Inc. share’s latest price of $38.29 as on September 17, 2025 at 8:42 pm IST, you will get 0.2612 shares of Agios Pharmaceuticals, Inc.. Learn more about fractional shares .

What are the returns that Agios Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Agios Pharmaceuticals, Inc. stock has given -6.13% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?